Statement of Principles concerning essential thrombocythaemia No. 16 of 2013

Administered by Department of Veterans' Affairs

Legislation au F2013L00411 Not in force Legislative Instrument

Legislation content

 

REPATRIATION MEDICAL AUTHORITY

 

INSTRUMENT NO. 16 of 2013

 

VETERANS’ ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

EXPLANATORY NOTES FOR TABLING

 

 

  1. The Repatriation Medical Authority (the Authority) has determined, under subsection 196B(3) of the Veterans’ Entitlements Act 1986 (the VEA), Statement of Principles Instrument No. 16 of 2013 concerning essential thrombocythaemia and death from essential thrombocythaemia.

 

2.             The Authority is of the view that on the sound medical-scientific evidence available it is more probable than not that essential thrombocythaemia and death from essential thrombocythaemia can be related to particular kinds of service.  The Authority has therefore determined this Statement of Principles concerning essential thrombocythaemia pursuant to subsection 196B(3) of the VEA.

 

3.             Pursuant to the provisions of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA), claims for pension under the VEA or compensation under the MRCA are determined by the Repatriation Commission or the Military Rehabilitation and Compensation Commission by reference to Statements of Principles issued by the Authority pursuant to the VEA.

 

4.             The Statement of Principles sets out the factors that must exist, and which of those factors must be related to the following kinds of service rendered by a person:

 

 eligible war service (other than operational service) under the VEA;

 defence service (other than hazardous service and British nuclear test defence service) under the VEA;

 peacetime service under the MRCA,

 

before it can be said that, on the balance of probabilities, essential thrombocythaemia or death from essential thrombocythaemia is connected with the circumstances of that service.

 

5.             The Repatriation Commission, Military Rehabilitation and Compensation Commission, Veterans’ Review Board or Administrative Appeals Tribunal cannot accept any claim for pension; or a claim for liability or compensation relating to essential thrombocythaemia or death from essential thrombocythaemia that was lodged on or after 1 June 1994 in the case of the VEA, or 1 July 2004 in the case of the MRCA respectively, unless this Statement of Principles upholds that claim (subsection 120B(3) of the VEA or subsection 339(3) of the MRCA).

 

6.             This new Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 23 March 2011 concerning JAK-related myeloproliferative disorders (including essential thrombocythaemia and myelofibrosis) in accordance with section 196G of the VEA.  The investigation involved an examination of the sound medical-scientific evidence available to the Authority.

 

7.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to JAK-related myeloproliferative disorders (including essential thrombocythaemia and myelofibrosis) in the Government Notices Gazette of 23 March 2011, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  One submission was received for consideration by the Authority during the investigation.

 

8.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011. A Statement of Compatibility with Human Rights follows.

 

9.             The determining of this new Instrument finalises the investigation in relation to JAK-related myeloproliferative disorders (including essential thrombocythaemia and myelofibrosis) as advertised in the Government Notices Gazette of 23 March 2011.

 

10.         A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA.  Any such request must be made in writing to the Repatriation Medical Authority at the following address:

 

The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Statement of Principles No. 16 of 2013

Kind of Injury, Disease or Death: Essential thrombocythaemia

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have essential thrombocythaemia;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal; and
  • outlines the factors which the current sound medical-scientific evidence indicates must exist before it can be said that, on the balance of probabilities, essential thrombocythaemia is connected with the circumstances of eligible service rendered by a person, as set out in clause 4 of the Explanatory Notes.

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICSECR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICSECR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members; and
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Repatriation Medical Authority Instrument No. 16 of 2013 was enacted to address the issue of essential thrombocythaemia and death from essential thrombocythaemia in relation to veterans' entitlements. This instrument was established under the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. The Repatriation Medical Authority, acting under subsection 196B(3) of the VEA, determined that on the sound medical-scientific evidence available, it is more probable than not that essential thrombocythaemia and death from essential thrombocythaemia can be related to particular kinds of service. The policy objective is to provide clarity and facilitate claims for pension under the VEA or compensation under the MRCA by specifying the circumstances and factors necessary for a claim to be considered valid. The instrument ensures that only claims supported by this Statement of Principles, which outlines the necessary conditions and service-related factors, will be accepted by the relevant authorities. This approach aims to enhance the medico-scientific quality of outcomes and ensure that the qualifying conditions for benefits are reasonable, proportionate, and transparent, thereby promoting the human rights of veterans and their dependents.

Scope and Application

The Repatriation Medical Authority Instrument No. 16 of 2013, established under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, outlines the circumstances in which essential thrombocythaemia and death from essential thrombocythaemia can be related to particular kinds of service, thereby facilitating claims for pension or compensation. This instrument applies to individuals who have rendered eligible war service, defence service, or peacetime service, and who are seeking benefits under the VEA or MRCA. It mandates that any claim lodged on or after 1 June 1994 under the VEA, or 1 July 2004 under the MRCA, must be upheld by this Statement of Principles to be considered valid. The instrument is designed to improve the medico-scientific quality of outcomes by specifying the required medical evidence and service-related factors, ensuring that the process for determining such claims is transparent and equitable. Additionally, it promotes various human rights, including the right to social security and an adequate standard of living, by facilitating the assessment and determination of benefits.

Key Provisions

The main operative sections of the Repatriation Medical Authority Instrument No. 16 of 2013 (the Instrument) pertain to the determination of essential thrombocythaemia and death from essential thrombocythaemia in relation to service rendered by a person. Specifically, under subsection 196B(3) of the Veterans’ Entitlements Act 1986 (VEA), the Repatriation Medical Authority (the Authority) has determined a Statement of Principles (No. 16 of 2013) concerning essential thrombocythaemia. This Statement of Principles outlines the factors that must exist and be related to particular kinds of service before it can be said that essential thrombocythaemia or death from essential thrombocythaemia is connected with the circumstances of that service. Claims for pension under the VEA or compensation under the Military Rehabilitation and Compensation Act 2004 (MRCA) can only be considered if the Statement of Principles upholds the claim. The Instrument imposes obligations on the Repatriation Commission, Military Rehabilitation and Compensation Commission, Veterans’ Review Board, and the Administrative Appeals Tribunal to assess claims for pension or compensation in accordance with the Statement of Principles. Specifically, these bodies cannot accept any claim for pension or compensation relating to essential thrombocythaemia or death from essential thrombocythaemia that was lodged after 1 June 1994 for the VEA or 1 July 2004 for the MRCA, unless the claim is upheld by the Statement of Principles. The Authority is also required to ensure that the Instrument is compatible with human rights as recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011. The Instrument does not explicitly state any offences, penalties, or civil/criminal consequences for breach. However, failure to comply with the Statement of Principles could result in the rejection of a claim for pension or compensation. This could have significant financial and health consequences for the claimant and their dependents. Additionally, the Instrument states that it is compatible with human rights and does not derogate from any human rights, promoting the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents. This suggests that any breach of the Instrument could be seen as a breach of human rights, which could have legal consequences. In conclusion, the Repatriation Medical Authority Instrument No. 16 of 2013 sets out the factors that must exist and be related to particular kinds of service before it can be said that essential thrombocythaemia or death from essential thrombocythaemia is connected with the circumstances of that service. It imposes obligations on the Repatriation Commission, Military Rehabilitation and Compensation Commission, Veterans’ Review Board, and the Administrative Appeals Tribunal to assess claims for pension or compensation in accordance with the Statement of Principles. Failure to comply with the Instrument could result in the rejection of a claim for pension or compensation, which could have significant financial and health consequences for the claimant and their dependents. The Instrument is also compatible with human rights and does not derogate from any human rights.

Legal classification tags

Area of Law
Veterans’ Law
Instrument
Instrument
Concepts
Definitions & Interpretation
Regulatory Standards
Human Rights Law
Catchwords
Statement of Principles

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.